Significance of cyclin D1 overexpression in progression and radio-resistance of pediatric ependymomas

Muh Lii Liang, Tsung Han Hsieh, Yun Ru Liu, Yi Wei Chen, Yi Yen Lee, Feng Chi Chang, Shih Chieh Lin, Ming Chao Huang, Donald Ming Tak Ho, Tai-Tong Wong, Yun Yen, Muh Hwa Yang

Research output: Contribution to journalArticle

2 Citations (Scopus)

Abstract

Due to the limited efficacy of chemotherapy, the applications of adjuvant irradiation play an important role for ependymoma treatment. However, in the young ages, the resistance of residual and recurrent tumor, and long-term intellectual sequelae remain the major obstacles of radiotherapy. Understanding the mechanism of therapeutic failure caused by radio-resistance is, therefore, crucial in ependymoma treatment. Here we retrospectively analyze clinic-pathological factors in 82 cases of ependymoma less than 20 years old and identify radio-resistant genes through gene expression microarray followed by qRT-PCR validation and immunohistochemistry staining. Thirty-one out of 82 (37.8%) patients are under 3-year-old. The 10 years PFS and OS are 38% and 60%. Gross-total resection is the single significant prognostic factor for longer 10 years PFS and OS in the multivariant analysis (p < 0.05). According to the microarray analysis, CCND1 is up-regulated in supratentorial and infratentorial ependymomas and is associated with DNA repair. We demonstrated that 24 primary and 16 recurrent ependymomas were up-regulated, and 5 out of 7 paired samples exhibited higher CCND1 expression in recurrent tumors. We also found RAD51, another DNA repair gene, was up-regulated in supratentorial and infratentorial ependymomas. Knocking down CCND1 reduced cell proliferation and repressed several genes associated with S-phase and DNA repair. Homologous recombination activities of DNA repair were significantly decreased in CCND1-deficient cells while the level of γH2AX was increased after irradiation. In summary, these observations suggest a robust role of CCND1 in regulating cell proliferation and radio-resistance in ependymomas, providing a potential therapeutic target for pediatric ependymomas.

Original languageEnglish
Pages (from-to)2527-2542
Number of pages16
JournalOncotarget
Volume9
Issue number2
DOIs
Publication statusPublished - Jan 1 2018

Fingerprint

Ependymoma
Cyclin D1
Radio
Pediatrics
DNA Repair
Cell Proliferation
Genes
Recombinational DNA Repair
Residual Neoplasm
Therapeutics
Adjuvant Chemotherapy
Microarray Analysis
S Phase
Radiotherapy
Immunohistochemistry
Staining and Labeling
Gene Expression
Polymerase Chain Reaction

Keywords

  • CCND1
  • Ependymoma
  • Pediatric
  • Radio-resistance

ASJC Scopus subject areas

  • Oncology

Cite this

Liang, M. L., Hsieh, T. H., Liu, Y. R., Chen, Y. W., Lee, Y. Y., Chang, F. C., ... Yang, M. H. (2018). Significance of cyclin D1 overexpression in progression and radio-resistance of pediatric ependymomas. Oncotarget, 9(2), 2527-2542. https://doi.org/10.18632/oncotarget.23509

Significance of cyclin D1 overexpression in progression and radio-resistance of pediatric ependymomas. / Liang, Muh Lii; Hsieh, Tsung Han; Liu, Yun Ru; Chen, Yi Wei; Lee, Yi Yen; Chang, Feng Chi; Lin, Shih Chieh; Huang, Ming Chao; Ho, Donald Ming Tak; Wong, Tai-Tong; Yen, Yun; Yang, Muh Hwa.

In: Oncotarget, Vol. 9, No. 2, 01.01.2018, p. 2527-2542.

Research output: Contribution to journalArticle

Liang, ML, Hsieh, TH, Liu, YR, Chen, YW, Lee, YY, Chang, FC, Lin, SC, Huang, MC, Ho, DMT, Wong, T-T, Yen, Y & Yang, MH 2018, 'Significance of cyclin D1 overexpression in progression and radio-resistance of pediatric ependymomas', Oncotarget, vol. 9, no. 2, pp. 2527-2542. https://doi.org/10.18632/oncotarget.23509
Liang, Muh Lii ; Hsieh, Tsung Han ; Liu, Yun Ru ; Chen, Yi Wei ; Lee, Yi Yen ; Chang, Feng Chi ; Lin, Shih Chieh ; Huang, Ming Chao ; Ho, Donald Ming Tak ; Wong, Tai-Tong ; Yen, Yun ; Yang, Muh Hwa. / Significance of cyclin D1 overexpression in progression and radio-resistance of pediatric ependymomas. In: Oncotarget. 2018 ; Vol. 9, No. 2. pp. 2527-2542.
@article{a3675557d53e4c5889fadbac15273eb7,
title = "Significance of cyclin D1 overexpression in progression and radio-resistance of pediatric ependymomas",
abstract = "Due to the limited efficacy of chemotherapy, the applications of adjuvant irradiation play an important role for ependymoma treatment. However, in the young ages, the resistance of residual and recurrent tumor, and long-term intellectual sequelae remain the major obstacles of radiotherapy. Understanding the mechanism of therapeutic failure caused by radio-resistance is, therefore, crucial in ependymoma treatment. Here we retrospectively analyze clinic-pathological factors in 82 cases of ependymoma less than 20 years old and identify radio-resistant genes through gene expression microarray followed by qRT-PCR validation and immunohistochemistry staining. Thirty-one out of 82 (37.8{\%}) patients are under 3-year-old. The 10 years PFS and OS are 38{\%} and 60{\%}. Gross-total resection is the single significant prognostic factor for longer 10 years PFS and OS in the multivariant analysis (p < 0.05). According to the microarray analysis, CCND1 is up-regulated in supratentorial and infratentorial ependymomas and is associated with DNA repair. We demonstrated that 24 primary and 16 recurrent ependymomas were up-regulated, and 5 out of 7 paired samples exhibited higher CCND1 expression in recurrent tumors. We also found RAD51, another DNA repair gene, was up-regulated in supratentorial and infratentorial ependymomas. Knocking down CCND1 reduced cell proliferation and repressed several genes associated with S-phase and DNA repair. Homologous recombination activities of DNA repair were significantly decreased in CCND1-deficient cells while the level of γH2AX was increased after irradiation. In summary, these observations suggest a robust role of CCND1 in regulating cell proliferation and radio-resistance in ependymomas, providing a potential therapeutic target for pediatric ependymomas.",
keywords = "CCND1, Ependymoma, Pediatric, Radio-resistance",
author = "Liang, {Muh Lii} and Hsieh, {Tsung Han} and Liu, {Yun Ru} and Chen, {Yi Wei} and Lee, {Yi Yen} and Chang, {Feng Chi} and Lin, {Shih Chieh} and Huang, {Ming Chao} and Ho, {Donald Ming Tak} and Tai-Tong Wong and Yun Yen and Yang, {Muh Hwa}",
year = "2018",
month = "1",
day = "1",
doi = "10.18632/oncotarget.23509",
language = "English",
volume = "9",
pages = "2527--2542",
journal = "Oncotarget",
issn = "1949-2553",
publisher = "Impact Journals LLC",
number = "2",

}

TY - JOUR

T1 - Significance of cyclin D1 overexpression in progression and radio-resistance of pediatric ependymomas

AU - Liang, Muh Lii

AU - Hsieh, Tsung Han

AU - Liu, Yun Ru

AU - Chen, Yi Wei

AU - Lee, Yi Yen

AU - Chang, Feng Chi

AU - Lin, Shih Chieh

AU - Huang, Ming Chao

AU - Ho, Donald Ming Tak

AU - Wong, Tai-Tong

AU - Yen, Yun

AU - Yang, Muh Hwa

PY - 2018/1/1

Y1 - 2018/1/1

N2 - Due to the limited efficacy of chemotherapy, the applications of adjuvant irradiation play an important role for ependymoma treatment. However, in the young ages, the resistance of residual and recurrent tumor, and long-term intellectual sequelae remain the major obstacles of radiotherapy. Understanding the mechanism of therapeutic failure caused by radio-resistance is, therefore, crucial in ependymoma treatment. Here we retrospectively analyze clinic-pathological factors in 82 cases of ependymoma less than 20 years old and identify radio-resistant genes through gene expression microarray followed by qRT-PCR validation and immunohistochemistry staining. Thirty-one out of 82 (37.8%) patients are under 3-year-old. The 10 years PFS and OS are 38% and 60%. Gross-total resection is the single significant prognostic factor for longer 10 years PFS and OS in the multivariant analysis (p < 0.05). According to the microarray analysis, CCND1 is up-regulated in supratentorial and infratentorial ependymomas and is associated with DNA repair. We demonstrated that 24 primary and 16 recurrent ependymomas were up-regulated, and 5 out of 7 paired samples exhibited higher CCND1 expression in recurrent tumors. We also found RAD51, another DNA repair gene, was up-regulated in supratentorial and infratentorial ependymomas. Knocking down CCND1 reduced cell proliferation and repressed several genes associated with S-phase and DNA repair. Homologous recombination activities of DNA repair were significantly decreased in CCND1-deficient cells while the level of γH2AX was increased after irradiation. In summary, these observations suggest a robust role of CCND1 in regulating cell proliferation and radio-resistance in ependymomas, providing a potential therapeutic target for pediatric ependymomas.

AB - Due to the limited efficacy of chemotherapy, the applications of adjuvant irradiation play an important role for ependymoma treatment. However, in the young ages, the resistance of residual and recurrent tumor, and long-term intellectual sequelae remain the major obstacles of radiotherapy. Understanding the mechanism of therapeutic failure caused by radio-resistance is, therefore, crucial in ependymoma treatment. Here we retrospectively analyze clinic-pathological factors in 82 cases of ependymoma less than 20 years old and identify radio-resistant genes through gene expression microarray followed by qRT-PCR validation and immunohistochemistry staining. Thirty-one out of 82 (37.8%) patients are under 3-year-old. The 10 years PFS and OS are 38% and 60%. Gross-total resection is the single significant prognostic factor for longer 10 years PFS and OS in the multivariant analysis (p < 0.05). According to the microarray analysis, CCND1 is up-regulated in supratentorial and infratentorial ependymomas and is associated with DNA repair. We demonstrated that 24 primary and 16 recurrent ependymomas were up-regulated, and 5 out of 7 paired samples exhibited higher CCND1 expression in recurrent tumors. We also found RAD51, another DNA repair gene, was up-regulated in supratentorial and infratentorial ependymomas. Knocking down CCND1 reduced cell proliferation and repressed several genes associated with S-phase and DNA repair. Homologous recombination activities of DNA repair were significantly decreased in CCND1-deficient cells while the level of γH2AX was increased after irradiation. In summary, these observations suggest a robust role of CCND1 in regulating cell proliferation and radio-resistance in ependymomas, providing a potential therapeutic target for pediatric ependymomas.

KW - CCND1

KW - Ependymoma

KW - Pediatric

KW - Radio-resistance

UR - http://www.scopus.com/inward/record.url?scp=85040010232&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=85040010232&partnerID=8YFLogxK

U2 - 10.18632/oncotarget.23509

DO - 10.18632/oncotarget.23509

M3 - Article

AN - SCOPUS:85040010232

VL - 9

SP - 2527

EP - 2542

JO - Oncotarget

JF - Oncotarget

SN - 1949-2553

IS - 2

ER -